Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.

Most relapsing MS patients on Mavenclad did not have confirmed disability progression for at least four years, new Phase 4 ...

Daily treatment with atogepant maintains long-term safety, efficacy, and functional benefits over 1 year in patients with chronic and episodic migraine.

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.

Medical experts warn against treating over-the-counter supplements the same as leucovorin, the drug the Trump administration has touted as an autism treatment.

MIBC requires a multimodal treatment approach, with radical cystectomy as the gold standard and bladder-sparing options for select patients. Adjuvant immunotherapies, such as nivolumab and ...

Emma Guttman-Yassky, MD, PhD, discusses the long-term efficacy of deuruxolitinib in alopecia areata.

Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...

A research team working at MedUni Vienna has demonstrated that a specific component of the immune system (PTX-3) remains at ...

A research team working at MedUni Vienna has demonstrated that a specific component of the immune system (PTX-3) remains at significantly higher levels in the blood of patients who have suffered from ...

Getting vaccinated, Chen says, is an important first step in protecting against possible Long COVID. However, the study shows ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...